Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

Clinical trial NCT00126607 · TERMINATED

Trial details

NCT number: NCT00126607
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

High-grade Salivary Gland Mucoepidermoid Carcinoma Recurrent Salivary Gland Cancer Salivary Gland Acinic Cell Tumor Salivary Gland Adenocarcinoma Salivary Gland Poorly Differentiated Carcinoma Stage IVA Salivary Gland Cancer Stage IVB Salivary Gland Cancer Stage IVC Salivary Gland Cancer

Start date: 2005-07-01
Primary completion: 2007-05-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.